R5 News
Major Advance in France for R5
R5 Pharmaceuticals Ltd, a leading provider of contract pharmaceutical sciences outsourcing services ... Read More
Third QP appointed at R5
R5 is pleased to announce the appointment of David Porter BSc (Hons) Pharmacy, MSc, as QP in the Qua... Read More
R5 reaches National Award Finals
Medilink UK has included R5 Pharmaceuticals in its National Finals for the UK Export Achievemen... Read More
R5 roars into 2010
R5 continues to experience business growth and we are pleased to announce the placing of projects fr... Read More
R5 Pharmaceuticals Ltd.
R5 develops and manufactures new medicines and clinical trial materials for Phase 1 and Phase 2 clinical trials.
Our projects include most dosage forms and all are produced at R5's GMP labs.
R5 is licensed by MHRA for the GMP manufacture and testing of Investigational Medical Products (IMPs) and Specials.
 |
 |
 |
 |
 |